SCHEMBL22021176

SCHEMBL22021176

Cc1cn(C(C)C)nc1S(=O)(=O)N[Si](C)(C)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
NR1H4 Q96RI1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24978306 0.84 ADORA2A (0.35) ADORA2AADORA1
SCHEMBL29056885 0.81
SCHEMBL21963174 0.77 BACE1 (0.30)
SCHEMBL21962514 0.74
SCHEMBL21963068 0.73
SCHEMBL22021177 0.73
SCHEMBL24979080 0.73 NLRP3 (0.44)
SCHEMBL22021183 0.73 ADORA2A (0.36) ADORA2AADORA1
SCHEMBL22021180 0.73 ADORA2A (0.36) ADORA2AADORA1
SCHEMBL20699033 0.72 NLRP3 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed